Getting closer to physiologic insulin secretion

Clinical Therapeutics

Volumn 29, Issue SUPPL. D, 2007, Pages

  Heise, Tim ^a  

^a Profil Institute for Metabolic Research   (Germany)

Author keywords

euglycemic clamp; insulin analogues; insulin aspart; type 1 diabetes mellitus; type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN GLULISINE; INSULIN LISPRO;

AREA UNDER THE CURVE; ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; EATING; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESPONSE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PREGNANCY DIABETES MELLITUS;

AGED; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; DIABETES, GESTATIONAL; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; POSTPRANDIAL PERIOD; PREGNANCY;

EID: 38049059273     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.12.012     Document Type: Article

References (21)

1. Nesher R., and Cerasi E. Modeling phasic insulin release: Immediate and time-dependent effects of glucose. Diabetes 51 Suppl 1 (2002) S53-S59
2. Bruce D., Chisholm D., Storlien L., and Kraegen E. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 37 (1988) 736-744
3. Heinemann L., Traut T., and Heise T. Time-action profile of inhaled insulin. Diabet Med. 14 (1997) 63-72
4. Nosek L., Heinemann L., Kaiser M., et al. No increase in the duration of action with rising doses of insulin aspart. Diabetes 52 Suppl 1 (2003) A128 Abstract
5. Overmann H., and Heinemann L. Injection-meal interval: Recommendations of diabetologists and how patients handle it. Diabetes Res Clin Pract 43 (1999) 137-142
6. Brunner G., Hirschberger S., Sendlhofer G., et al. Postprandial administration of the insulin analogue insulin aspart in patients with type 1 diabetes mellitus. Diabet Med 17 (2000) 371-375
7. Berger M. Towards more physiological insulin therapy in the 1990s. A comment. Diabetes Res Clin Pract 6 (1989) S25-S31
8. Brange J., and Volund A. Insulin analogs with improved pharmacokinetic profiles. Adv Drug Deliv Rev 35 (1999) 307-335
9. Heinemann L., and Woodworth J. Insulin lispro. Chapter III: Pharmacokinetics and metabolism of insulin lispro. Drugs Today 34 Suppl C (1998) 23-36
10. Heinemann L., Heise T., Wahl L., et al. Prandial glycaemia after a carbohydrate-rich meal in type 1 diabetic patients: Using the rapid acting insulin analogue (Lys[B28], Pro[B29]) human insulin. Diabet Med 13 (1996) 625-629
11. Muhlhauser I., Toth G., Sawicki P., and Berger M. Severe hypoglycemia in type 1 diabetic patients with impaired kidney function. Diabetes Care 14 (1991) 344-346
12. Bending J., Pickup J., Viberti G., and Keen H. Glycaemic control in diabetic nephropathy. Br Med J (Clin Res Ed) 288 (1984) 1187-1191
13. Rave K., Heise T., Pfutzner A., et al. Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of insulin in type 1 diabetic patients. Diabetes Care 24 (2001) 886-890
14. Pettitt D., Ospina P., Kolaczynski J., and Jovanovic L. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care 26 (2003) 183-186
15. Mathiesen E., Kinsley B., Amiel S., et al., for the Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 30 (2007) 771-776
16. Hod M., Damm P., Kaaja R., et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: A randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol (2007) Sept 29 [Epub ahead of print]. doi:10.1016/j.ajog.2007.08.005
17. Jovanovic L., Giammattei J., Acquistapace M., et al. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size. Clin Ther 26 (2004) 1492-1497
18. Schernthaner G., Wein W., Sandholzer K., et al. Postprandial insulin in paediatric subjects with type 1 dialispro. A new therapeutic option for type 1 diabetic patients. Diabetes Care 21 (1998) 570-573
19. Krones R., Heise T., Basir S., et al. Time-action profiles of insulin as-part and human regular insulin in elderly and middle-aged subjects withtype 2 diabetes. Diabetes 53 Suppl 2 (2004) A133 Abstract
20. Mortensen H., Lindholm A., Olsen B., and Hylleberg B. Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 dia-betes. Eur J Pediatr 159 (2000) 483-488
21. Holmes G., Galitz L., Hu P., and Lyness W. Pharmacokinetics of insulin aspart in obesity, renal impairment, or he-patic impairment. Br J Clin Pharmacol 60 (2005) 469-476